Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. 2007

Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
EA 2962-Pharmacochimie, UFR des Sciences Pharmaceutiques, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France. Jean.Guillon@chimphys.u-bordeaux2.fr

An original series of 4-substituted pyrrolo[1,2-a]quinoxaline derivatives, new structural analogues of Galipea species quinoline alkaloids, was synthesized from various substituted 2-nitroanilines via multistep heterocyclizations and tested for in vitro antiparasitic activity upon Leishmania amazonensis and Leishmania infantum strains. Structure-activity relationships enlighten the importance of the 4-substituted alkenyl side chain on the pyrrolo[1,2-a]quinoxaline moiety to modulate the antileishmanial activity.

UI MeSH Term Description Entries
D007891 Leishmania A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi. Leishmania (Leishmania),Leishmania (Viannia),Leishmania leishmania,Leishmania viannia,Leishmania leishmanias,Leishmania viannias,Leishmanias,Leishmanias (Leishmania),Leishmanias (Viannia),leishmanias, Leishmania,viannias, Leishmania
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011810 Quinoxalines Quinoxaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
June 2014, European journal of medicinal chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
August 2014, European journal of medicinal chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
September 2003, Farmaco (Societa chimica italiana : 1989),
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
May 2021, Molecular diversity,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
December 2012, European journal of medicinal chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
August 2021, European journal of medicinal chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
May 2018, European journal of medicinal chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
November 2011, Organic & biomolecular chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
November 2013, European journal of medicinal chemistry,
Jean Guillon, and Isabelle Forfar, and Maria Mamani-Matsuda, and Vanessa Desplat, and Marion Saliège, and Denis Thiolat, and Stéphane Massip, and Anais Tabourier, and Jean-Michel Léger, and Benoit Dufaure, and Gilbert Haumont, and Christian Jarry, and Djavad Mossalayi
September 2006, European journal of medicinal chemistry,
Copied contents to your clipboard!